Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib

Overview of attention for article published in PLOS ONE, February 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 39,940 followers.

Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Bortezomib http://t.co/wdwUcY4zFk HT @Myeloma_Doc

Velcade in #myeloma cells: similar proteasome site inhibition produces different influence on protein breakdown (http://t.co/tAx93fRsXd).

Velcade in #myeloma cells: similar proteasome site inhibition produces different influence on protein breakdown (http://t.co/tAx93fRsXd).

Velcade in #myeloma cells: similar proteasome site inhibition produces different influence on protein breakdown (http://t.co/tAx93fRsXd).